Incremental Effectiveness of Iptacopan Compared with C5 Inhibitors in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from a Modelling Analysis

Poster Presentation
© 2024 American Society of Hematology. All rights reserved.
Meeting: 2024 ASH® Annual Meeting
Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Presenter: Shreyans Gandhi, MD, MBBS, DNB, FRCPath, MPhil, MRCP
Affiliation: Kings College Hospital, NHS Foundation Trust, London, United Kingdom
Presentation Date: December 9, 2024
Abstract Number: 5012
Session: Session: 901. Health Services and Quality Improvement: Non-Malignant Conditions Excluding Hemoglobinopathies: Poster III
Related content: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Poster Presentation
Abstract Number: 2327
Presenter: David Dingli, MD, PhD
Indication: Paroxysmal Nocturnal Hemoglobinuria (PNH)
Date Presented: December 7, 2024

To access this content please accept the following declarations.

This content was selected by and is provided to you upon your unsolicited request courtesy of Novartis with permission of ASH®.